Evaluation of modified carbapenem inactivation method for suspected carbapenemase among Enterobacteriaceae clinical isolates

Oncotarget
Beiwei YuFupin Hu

Abstract

Modified carbapenem inactivation method (mCIM) testing was currently recommended by Clinical and Laboratory Standards Institute (CLSI) for detection of carbapenemase among Enterobacteriaceae clinical isolates. In this study, a panel of 145 clinical strains were collected for evaluating the mCIM for detection of carbapenemase. Antimicrobial susceptibility testing were performed by microbroth dilution and the results were interpreted according to CLSI guidelines. All strains were resistant to ertapenem with high MIC50 and MIC90 (64 mg/L ->128 mg/L). For blaNDM-1-positive or blaOXA-232-positive strains, the zone of inhibition of meropenem were all 6 mm despite the incubation time of 6 h, 18 h or 24 h. For 6 h, the zone of meropenem inhibition for most of carbapenemase-positive isolates were meet the positive criteria 6-15 mm. However, for carbapenemase-negative isolates, the zone of meropenem inhibition were 16-18 mm after 6 h incubation which should be considered indeterminate for standard incubating time such as 18 h or 24 h. After incubating for 18 h or 24 h, the zone of meropenem inhibition were 22-25 mm for carbapenemase-negative isolates and meet the negative criteria. Our study indicate mCIM is a simple and effective method...Continue Reading

References

Aug 2, 2007·The Annals of Pharmacotherapy·Katherine Yang, B Joseph Guglielmo
Jun 16, 2009·The Journal of Antimicrobial Chemotherapy·Spyros PournarasDanai Sofianou
Jun 2, 2012·BMJ : British Medical Journal·Peter M Hawkey, David M Livermore
Jun 16, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Latania K Logan
Aug 1, 2015·Journal of Clinical Microbiology·Alix PantelJean-Philippe Lavigne
Jan 8, 2016·Journal of Clinical Microbiology·Joseph D Lutgring, Brandi M Limbago
Jan 25, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J ZhuF Hu
Mar 24, 2016·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·F-P HuW Huang

❮ Previous
Next ❯

Citations

Oct 4, 2020·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Gulsen Altinkanat GelmezGuner Soyletir

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.